support@yingchitech.com
YINGCHI New Study | 4 days for rapid onset, 6 months of sustained relief! “Sequential Dual-Target” accelerated rTMS: A new treatment protocol for depression
Major Depressive Disorder (MDD) is the leading cause of disability worldwide. Traditional medications and psychotherapy have limited efficacy in some patients. Although repetitive transcranial magnetic stimulation (rTMS) has been approved for MDD, the standard protocol has drawbacks including long treatment duration and slow onset of action. To improve treatment efficiency, reduce costs, and increase accessibility,... Read more
YINGCHI TMS | YINGCHI at SfN 2025: Learning, Sharing, Connecting
Date/Time :November 15-19, 2025 Location : San Diego, CA Official Congress Website：https://www.sfn.org/meetings/neuroscience-2025 YINGCHI Booth: #2910 Every year, the SfN annual meeting brings together thousands of scientists to discuss new findings, share ideas, and explore how neuroscience can continue to move forward. Its long-standing mission is to support scientific progress, encourage open exchange, and strengthen collaboration across different fields... Read more
